ANKDD1A and central nervous system cancer: The TCGA database analysis (G4502A) indicated that ANKDD1A had decreased the expression in glioma compared with normal brain tissues (Fig. 1a), and this expression pattern was further confirmed by real-time PCR in glioma tissues (n = 27) and normal brain tissues (n = 10) (Fig. 1b).